Quantitative Sensory Testing to assess the sensory characteristics of cancer‐induced bone pain after radiotherapy and potential clinical biomarkers of response

[1]  R. Moore,et al.  WITHDRAWN: Radiotherapy for the palliation of painful bone metastases. , 2013, The Cochrane database of systematic reviews.

[2]  P. Mantyh,et al.  Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain , 2010, Neuroscience.

[3]  M. Bennett,et al.  Neuropathic pain features in patients with bone metastases referred for palliative radiotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  P. Mantyh,et al.  Pathological Sprouting of Adult Nociceptors in Chronic Prostate Cancer-Induced Bone Pain , 2010, The Journal of Neuroscience.

[5]  G. Cruccu,et al.  EFNS guidelines on neuropathic pain assessment: revised 2009 , 2010, European journal of neurology.

[6]  B. Laird,et al.  Functional assessment predicts ability to complete trial follow-up in cancer-induced bone pain. , 2010 .

[7]  Lars Arendt-Nielsen,et al.  Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera. , 2009, The journal of pain : official journal of the American Pain Society.

[8]  L. Andrade-Ortega.  [Outcome measures]. , 2009, Reumatologia clinica.

[9]  David Cella,et al.  Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. , 2008, The journal of pain : official journal of the American Pain Society.

[10]  G. Wasner,et al.  Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system. , 2007, European journal of cancer.

[11]  E. Chow,et al.  Worst, average or current pain in the Brief Pain Inventory: which should be used to calculate the response to palliative radiotherapy in patients with bone metastases? , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[12]  W. Sze,et al.  Palliative radiotherapy trials for bone metastases: a systematic review. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  V. Scaioli,et al.  Peripheral neuropathy due to paclitaxel: study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (QST) and comparison with neurophysiological findings , 2007, Journal of Neuro-Oncology.

[14]  P. Warde,et al.  Pain flare in patients with bone metastases after palliative radiotherapy—a nested randomized control trial , 2007, Supportive Care in Cancer.

[15]  C. Cleeland.  The Measurement of Pain from Metastatic Bone Disease: Capturing the Patient's Experience , 2006, Clinical Cancer Research.

[16]  F. Birklein,et al.  Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values , 2006, PAIN.

[17]  R. Treede,et al.  Quantitative sensory testing: a comprehensive protocol for clinical trials , 2006, European journal of pain.

[18]  L. Jasmin,et al.  The analgesic effect of low dose focal irradiation in a mouse model of bone cancer is associated with spinal changes in neuro-mediators of nociception , 2006, Pain.

[19]  M. Fallon,et al.  Alterations in evoked sensory responses in cancer-induced bone pain(CIBP) , 2006 .

[20]  J. Seong,et al.  Alteration of cancer pain-related signals by radiation: proteomic analysis in an animal model with cancer bone invasion. , 2005, International journal of radiation oncology, biology, physics.

[21]  G. Wasner,et al.  Postherpetic neuralgia: Topical lidocaine is effective in nociceptor–deprived skin , 2005, Journal of Neurology.

[22]  J. Farrar,et al.  Core outcome measures for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.

[23]  J. Seong,et al.  Radiation‐Induced Alteration of Pain‐Related Signals in an Animal Model with Bone Invasion from Cancer , 2004, Annals of the New York Academy of Sciences.

[24]  H. Krämer,et al.  Thermal thresholds predict painfulness of diabetic neuropathies. , 2004, Diabetes care.

[25]  T. Jensen,et al.  Symptoms and signs in patients with suspected neuropathic pain , 2004, Pain.

[26]  C. Urch.  The pathophysiology of cancer-induced bone pain: current understanding , 2004, Palliative medicine.

[27]  A. Dickenson,et al.  Superficial dorsal horn neuronal responses and the emergence of behavioural hyperalgesia in a rat model of cancer-induced bone pain , 2004, Neuroscience Letters.

[28]  G. Cruccu,et al.  EFNS guidelines on neuropathic pain assessment , 2004, European journal of neurology.

[29]  P Alaei,et al.  Radiation Treatment Decreases Bone Cancer Pain, Osteolysis and Tumor Size , 2004, Radiation research.

[30]  M. Mason,et al.  Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials. , 2003, The Cochrane database of systematic reviews.

[31]  L. Deangelis,et al.  Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing , 1997, Journal of Neuro-Oncology.

[32]  N. Spielholz.  Quantitative sensory testing: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology , 2003, Neurology.

[33]  A. Dickenson,et al.  Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain , 2003, Pain.

[34]  R. Baron,et al.  Translation of symptoms and signs into mechanisms in neuropathic pain , 2003, Pain.

[35]  T. Wilt,et al.  Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy--a systematic review of randomised trials. , 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

[36]  P. Mantyh,et al.  Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain , 2002, Pain.

[37]  M. Tenhunen,et al.  Palliative radiotherapy in the treatment of skeletal metastases , 2002, European journal of pain.

[38]  P. Hoskin,et al.  International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  Augusto Caraceni,et al.  Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. , 2002, Journal of pain and symptom management.

[40]  B. Jeremic.  Single fraction external beam radiation therapy in the treatment of localized metastatic bone pain. A review. , 2001, Journal of pain and symptom management.

[41]  Jesse A. Berlin,et al.  Defining the clinically important difference in pain outcome measures , 2000, PAIN.

[42]  E. Kosek,et al.  Abnormalities of somatosensory perception in patients with painful osteoarthritis normalize following successful treatment , 2000, European journal of pain.

[43]  John T. Farrar,et al.  What Is Clinically Meaningful: Outcome Measures in Pain Clinical Trials , 2000, The Clinical journal of pain.

[44]  P. Mantyh,et al.  Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons , 2000, Neuroscience.

[45]  J. Regan,et al.  Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity , 2000, The Lancet.

[46]  R. Moore,et al.  Radiotherapy for the palliation of painful bone metastases. , 2000, The Cochrane database of systematic reviews.

[47]  P. Mantyh,et al.  Neurochemical and Cellular Reorganization of the Spinal Cord in a Murine Model of Bone Cancer Pain , 1999, The Journal of Neuroscience.

[48]  A. Caraceni,et al.  An international survey of cancer pain characteristics and syndromes , 1999, PAIN.

[49]  Paul Jacobsen,et al.  Breakthrough pain: characteristics and impact in patients with cancer pain , 1999, Pain.

[50]  D. Yarnitsky,et al.  Clinical applications of quantitative sensory testing (QST) , 1998, Journal of the Neurological Sciences.

[51]  R. Coleman.  Skeletal complications of malignancy , 1997, Cancer.

[52]  S. Mercadante.  Malignant bone pain: pathophysiology and treatment , 1996, Pain.

[53]  R. Donehower,et al.  Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies , 1994, Annals of neurology.

[54]  C. Cleeland,et al.  Pain assessment: global use of the Brief Pain Inventory. , 1994, Annals of the Academy of Medicine, Singapore.

[55]  R. Lipton,et al.  Large and small fibre type sensory dysfunction in patients with cancer. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[56]  A. Banning,et al.  Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic , 1991, Pain.

[57]  O. S. Nielsen,et al.  Bone metastases: pathophysiology and management policy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  T. Nurmikko,et al.  Somatosensory findings in postherpetic neuralgia. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[59]  M. Cousins.  International association for the study of pain , 1989, Pain.

[60]  R. Hoop,et al.  Vibration perception and thermoperception as quantitative measurements in the monitoring of cisplatin induced neurotoxicity , 1989, Journal of the Neurological Sciences.

[61]  O. S. Nielsen,et al.  Palliative irradiation of bone metastases. , 1989, Cancer treatment reviews.

[62]  R. Lipton,et al.  Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer. , 1987, Archives of neurology.

[63]  C. Cleeland,et al.  Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases , 1983, Pain.

[64]  D. Tong,et al.  The palliation of symptomatic osseous metastases final results of the study by the radiation therapy oncology group , 1982, Cancer.

[65]  H. Fruhstorfer,et al.  Method for quantitative estimation of thermal thresholds in patients. , 1976, Journal of neurology, neurosurgery, and psychiatry.

[66]  L. W. Brady.  Palliative irradiation. , 1969, JAMA.